157 related articles for article (PubMed ID: 32735552)
1. Progestogen addition with low-dose levonorgestrel intrauterine system in menopausal hormone treatment gives less normal breast tissue proliferation than oral norethisterone acetate or medroxyprogesterone acetate.
Lundström E; Virijevic I; Söderqvist G
Horm Mol Biol Clin Investig; 2020 Jul; 41(3):. PubMed ID: 32735552
[TBL] [Abstract][Full Text] [Related]
2. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Sangkomkamhang US; Lumbiganon P; Pattanittum P
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
[TBL] [Abstract][Full Text] [Related]
3. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
4. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Marslew U; Munk-Nielsen N; Nilas L; Riis BJ; Christiansen C
Maturitas; 1994 Oct; 19(3):225-37. PubMed ID: 7799829
[TBL] [Abstract][Full Text] [Related]
5. Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen.
Rees MC; Kuhl H; Engelstein M; Mattila L; Mäenpää J; Mustonen M;
Climacteric; 2004 Mar; 7(1):23-32. PubMed ID: 15259280
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo.
Murkes D; Lalitkumar PG; Leifland K; Lundström E; Söderqvist G
Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():12-5. PubMed ID: 22834417
[TBL] [Abstract][Full Text] [Related]
7. Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.
MacLennan AH; MacLennan A; Wenzel S; Chambers HM; Eckert K
Med J Aust; 1993 Jul; 159(2):102-6. PubMed ID: 8336583
[TBL] [Abstract][Full Text] [Related]
8. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
9. Cyclical progestogens for heavy menstrual bleeding.
Bofill Rodriguez M; Lethaby A; Low C; Cameron IT
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD001016. PubMed ID: 31425626
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Skouby SO; Gram J; Andersen LF; Sidelmann J; Petersen KR; Jespersen J
Am J Obstet Gynecol; 2002 May; 186(5):969-77. PubMed ID: 12015523
[TBL] [Abstract][Full Text] [Related]
11. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
12. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
13. A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen.
Mattsson LA; Skouby SO; Heikkinen J; Vaheri R; Mäenpää J; Timonen U
Climacteric; 2004 Mar; 7(1):59-69. PubMed ID: 15259284
[TBL] [Abstract][Full Text] [Related]
14. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Roach RE; Lijfering WM; Helmerhorst FM; Cannegieter SC; Rosendaal FR; van Hylckama Vlieg A
J Thromb Haemost; 2013 Jan; 11(1):124-31. PubMed ID: 23136837
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Saure A; Planellas J; Poulsen HK; Jaszczak P
Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
[TBL] [Abstract][Full Text] [Related]
16. Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis.
Somboonporn W; Panna S; Temtanakitpaisan T; Kaewrudee S; Soontrapa S
Menopause; 2011 Oct; 18(10):1060-6. PubMed ID: 21720280
[TBL] [Abstract][Full Text] [Related]
17. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
19. Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens.
Ørbo A; Arnes M; Vereide AB; Straume B
BJOG; 2016 Aug; 123(9):1512-9. PubMed ID: 26630538
[TBL] [Abstract][Full Text] [Related]
20. Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women.
Lalitkumar PGL; Lundström E; Byström B; Ujvari D; Murkes D; Tani E; Söderqvist G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
